chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Same day as vax, the pt developed "complete amnesia". By the time he returned to MD's office on 10/12, he was able to recognize his wife and the MD and could correctly remember the names of his dogs. However, he was unable to recall the events of the day of the vax. He is to be evaluated by a neurologist. He has had flu shots many times before without problems.
2" area of swelling, redness, tenderness, warmth. Gave Keflex 2 weeks later area better.
around the week of Feb 15th had a hard rope feeling went from arm pit, half way down left arm toward elbow, it was painful and very taunt feeling, went to physician office no testing at this time
Information received form a woman concerning her child who was IZ with 1.5 ml of hepatitis B vax recombinant instead of 0.5 ml. The pt experienced redness at the injection site. No further information is available.
Patient came to the pharmacy to get her second COVID vaccine but did not bring her CDC card. Pharmacy technician filled out a new card for her and she ended up getting Pfizer for her second dose and Moderna for her first dose.
About a week after shot I had a red mark on arm and I thought I had hit myself but the rash spread towards my elbow. It didn't itch, it was just a rash. I read about this rash on the internet but I did still check with a Doctor and he confirmed that it was that and it would go away on it's own, and it did. It lasted about a week but by the time I seen a Doctor it was at it's worst and it got better.
Extreme tight pain at injection site, throat tightness, dryness and swelling. Ice applied to injection site, given Epinephrine 0.3 mg per EpiPen, methylprednisolone acetate 120 mg IM, diphenhydramine 50 mg IM.
Alopecia, fatigue, chronic nasal congestion, subarachnoid hemorrage after the anthrax vaccine.
On 11/17/06 patient experienced weakness, fatigue, aches, sweats.  Went to see doctor on 11/21/06 and doctor diagnosed patient with Bells Palsy. 03/15/07-records received from PCP for DOS 11/7/06-1/30/07- note dated 11/7/07-DX:Bell's Palsy. Visit 1/23/07-upper respiratory infection. Otalgia onleft side. 1/30/07-DX: otitis externa. PE:Opens/closes eyes without problem. Asymmetric smile.
she tested positive for COVID-19 in the rapid test; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (she tested positive for COVID-19 in the rapid test) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced COVID-19 (she tested positive for COVID-19 in the rapid test). At the time of the report, COVID-19 (she tested positive for COVID-19 in the rapid test) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Dec-2021, SARS-CoV-2 test: positive (Positive) She tested positive for COVID-19 in the rapid test.         No concomitant medications were reported.   No treatment details were reported.   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age with no reported medical history, who experienced the non-serious unexpected AESI event of COVID-19. The event occurred 2 days after the third dose of mRNA-1273 vaccine administration. Causality for the event of COVID-19 was not applicable to the product administration. The rechallenge was not applicable since the event occurred after the third dose and no further dosing is expected. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
pt devel fever, irritability, vomiting win 2hr of vax;pt became dehydrated, devel mucositis & was found to have kawasakis disease (mucocataneous lymph node synd) w/coronary artery deilation dx 6 day p/vax;
Patient presented to ED and was subsequently admitted to the hospital within 6 weeks of receiving COVID vaccination.
This is a spontaneous report from a contactable consumer (patient). An 84-year-old male patient received first dose of bnt162b2 (COVID 19, Pfizer, Solution for injection, Lot number: EL9262), via an unspecified route of administration on Left arm on 29Jan2021 14:00 at single dose for covid-19 immunisation. Medical history included high blood pressure and the patient also had PE. No allergies to medications, food, or other products was reported. The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included valsartan, metoprolol succinate (TOPROL), doxazosin mesilate (CARDURA), rivaroxaban (XARELTO); all received within 2 weeks of vaccination. The patient had neck pain and can't move head to either side without pain on 31Jan2021 14:00. No treatment was received for the adverse event. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
1-18-2018. Pt came back to pharmacy few days later and had bruising on her arm and stated she was having severe pain where shot was given. Pt stated bruising appeared 2 days post-administration.
pt admit to hospital on 10/15/21 with COVID pna, that was diagnosed on 10/9/21. He had received 2 doses of Moderna vaccine (2/4/21 & 3/4/21).
Side effects/Report adverse event; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Side effects/Report adverse event) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects/Report adverse event) and PYREXIA (Fever). At the time of the report, VACCINATION COMPLICATION (Side effects/Report adverse event) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
No report of adverse reaction from patient; inadvertently gave a monovalent vaccine which was beyond the published expiration date; 1st dose was on 10Jan2023, second dose on 27 feb2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently gave a monovalent vaccine which was beyond the published expiration date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose was on 10Jan2023, second dose on 27 feb2023) and NO ADVERSE EVENT (No report of adverse reaction from patient) in a 10-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 064A22A and 064A22A) for COVID-19 prophylaxis.     The patient had no relevant medical history/condition, allergy, concomitant diseases and risk factor. The patient had no other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 10-Jan-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 27-Feb-2023, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently gave a monovalent vaccine which was beyond the published expiration date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose was on 10Jan2023, second dose on 27 feb2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No report of adverse reaction from patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (inadvertently gave a monovalent vaccine which was beyond the published expiration date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose was on 10Jan2023, second dose on 27 feb2023) and NO ADVERSE EVENT (No report of adverse reaction from patient) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No report of adverse reaction from patient) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (inadvertently gave a monovalent vaccine which was beyond the published expiration date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose was on 10Jan2023, second dose on 27 feb2023).    The concomitant medication was not reported. The treatment medication was not reported. The patient was given monovalent vaccine (6 to 11 years) which was beyond the published expiration date, 24-Feb-2023.
Information has been received from a nurse practitioner concerning a female who on an unspecified date was vaccinated with the first dose of Gardasil (yeast). Subsequent following vaccination, the patient experiences extreme pain in the arm and inflammation. The patient underwent physical therapy and was diagnosed as having brachial neuritis. It was not specified if the series of Gardasil (yeast) would be completed. At the time of this report, the patient was recovering from the brachial neuritis. Additional information has been requested.
Double vision; FATIGUED; A spontaneous report was received from a consumer concerning a 65-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced double vision and fatigue.  The patient's medical history, as provided by the reporter included cancer, diabetes, hypertension, celiac disease and whipple's operation. No concomitant medications were reported.  On 21 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 029K20A) intramuscularly for prophylaxis of COVID-19 infection.   On 22 Jan 2021, the patient experienced double vision and fatigue. The patient was advised by the eye doctor to go into the emergency room (ER) if the symptoms didn't subside. However, it was reported that the vision did get better. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not provided.  The event, double vision, was considered resolved on an unknown date. The outcome for the event fatigue was unknown.; Reporter's Comments: Based on the current available information, a strong temporal association between the use of the product and the onset of the reported event, a causal relationship cannot be excluded. Fatigue is consistent with the known safety profile of the mRNA-1273 vaccine.
This case was reported by a physician and described the occurrence of hives in an approximately 66 year old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 2 November 2007 the subject received unspecified dose of Fluarix (unknown). At an unspecified time after vaccination with Fluarix, the subject experienced hives. At the time of reporting the outcome of the event was unspecified.
Patient reported rapid breathing rate and muscle rigidity in the arms for approx 20 minutes. After that she reported feeling 100% and needed no care or attention.
pt felt dizzy, like heart racing - pt had cold water & sat a few minutes longer then stated he was ok to leave.  Pt has parkinsons & wife said he gets anxiety.
LEGS WERE RUBBERY; TIRED FEELING FROM BOTTOM TO MY NECK/ARMS AND CHEST TIRED; HAD SHORTNESS OF BREATH; VERY LIGHT-HEADED/VERY DIZZY; FEEL BEAT UP; NO ENERGY; This spontaneous report received from a patient concerned an 81 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included atrial fibrillation, chronic bronchitis, macular degeneration, no alcohol use, and non smoker, and other pre-existing medical conditions included the patient had no known allergies.  The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 20UA21A, expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for atrial fibrillation, atorvastatin, calcium carbonate/colecalciferol, diltiazem, dofetilide, ergocalciferol, and spironolactone.  On 2021, the subject experienced feel beat up. On 2021, the subject experienced no energy. On 29-APR-2021, the subject experienced very light-headed/very dizzy. On 30-APR-2021, the subject experienced legs were rubbery. On 30-APR-2021, the subject experienced tired feeling from bottom to my neck/arms and chest tired. The action taken with covid-19 vaccine was not applicable. The patient recovered from very light-headed/very dizzy on 2021, and tired feeling from bottom to my neck/arms and chest tired on 05-MAY-2021, was recovering from feel beat up, and the outcome of legs were rubbery, no energy and had shortness of breath was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
A few hours after receiving the 1st dose of the vaccine, I started to feel a little disoriented, nausea and headache.  I went to get something to eat.  A few more hours went by and I started to feel worse.  I started feeling very tired and nausea. I went home to take a nap and woke up feeling even more sick, nausea, and warm/hot.  I tried to drink fluids  and thew up.  I was dripping in sweat and I passed out.  My friend had to call 911 and the ambulance took me to the ER.   At the hospital, they gave me a shot to help with the vomiting, IV fluids, blood work and they said I had pancreatitis.  I was discharged with prescription for nausea (Zofran).   The next day I felt significantly better, still tired,  By 2 days, I felt back to normal but still a little tired.
Fri Dec 3-small red spot on left arm. Sat Dec 4- Red, swollen and hot. Entire upper arm. Admitted to hospital IV antibiotics given oral antibiotics when released from hospital x7 more days.
Vaccines to include DTAP and IPV given yesterday afternoon.  Started c/o leg/knee pain last night.  Woke up this morning refusing to get out of bed and c/o leg/knee pain.  Redness, swelling, no fever.  Redness and swell started and thigh and moved down toward knee.  Whole legs with redness and swelling.  Pt c/o knee pain, and limping.  Pt. sent to pediatrics orthopedics for further evaluation.  At this time pt is doing well.
Rt. arm swollen, red, hard, warm to touch from shoulder to elbow and all aound the arm. No fever. Pediatrician recommended the use of Benadryl.
30 seconds after administration, pt stated she felt unwell, then began LOC with seizure lasting 1 minute. )2 administered, supportive care given. Transported to ER to eval by medics.
Patient at the line to add himself for 15 minutes observation. His mother, tells us that the patient is dizzy and also the nurse who administered the 3rd dose of Pfizer. The patient is transferred to the evaluation area in a wheelchair and is transferred to the stretcher. The HN proceeds to communicate with Doctor. The patient is left under observation for another 30 min. The lower extremities are kept elevated. at $:00 the patient is reassessed at all times, being alert, conscious and oriented. Doctor discharges him. The minor's mother leaves with him.
Hospitalization for shortness of breath due to a fall (tested positive for COVID-19) on dates 9/13/2023- 10/6/2023..  Treated with methylprednisolone.
Warmth at injection site Warm all over body Itchy tingling on my lips. Same feeling I have when I eat shrimp.
noticed swelling, redness, warmth, pain to L deltoid a day after receiving Tdap; also had flu-like symptoms with nightsweats and pain to the arm; by the 2nd day he took Ibuprofen and Tylenol for the pain but the pain and swelling persisted over the weekend.  reporting to facility today but still off; has not taken any more analgesics or antipyretics; has a bruise and redness to L deltoid
Child began to have emesis around 6/2/08 and progressed neurologically to vent. curd ICU for a time. Dr diagnosed with acute demyelinating encephalomyelitis.
Leg pain with difficulty walking  and redness starting within 12 hours of vaccine which led to an additional office visit
p/vax pt exp double vision; no treatment given; MRI & MRA, both nl results;
12pm - felt disoriented, didn't feel well, dizzy and had not eaten well. 9pm - trouble breathing, anxiety, and felt throat closing. Was taken to ER. At ER fluids were given. Also, medication to relax him and BENADRYL.
Could not move arm the 1st day due to pain & swelling at shot site.  Swelling gone the next day but still bright red & sore.  The next morning (12/1/2015) diarrhea, chills all day & bones ache all day.  Extreme fatigue, weakness & exhaustion that continues for the whole week.  Some mild headaches, light sensitivity, some nausea, total loss of appetite.  12/2/2015 go to ER about 6 pm because I am totally exhausted and can't hardly move around.  Dr. suggests I go to ER - he wants blood work & vitals.  ER gives me 1 L normal saline with Toradol.  Arm still pale red at shot site but not bright red anymore.  Continue to have no energy level.
Fever, chills, dis-oriented, flu like symptoms, elevated blood pressure, nausea for 3-4 days.
"Within 4 hrs got acute back pain in middle of back unusually intense 10/10/pain almost disabling. Had to stop normal activity. Now in remission. Dr. gave a pain killer."
Didn't feel as well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel as well) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Didn't feel as well). At the time of the report, MALAISE (Didn't feel as well) had resolved.            No concomitant medication was reported   No treatment medication was reported   This case was linked to MOD-2021-368921 (Patient Link).
Arm burns after shot then it went away but later that evening it hurt to the point where I could barely lift it. That lasted about 4-5 days.  Almost a week after I developed an itchy , raised Rash on my right arm where the shot was
Mother called at 1:10 PM & describe red blotches all over child's face.  The child told mother it was itchy.  Dr's office was notified.  Spoke with Dr. in same practice, who said mother should give 2 tsps of Children's Benadryl.  Mother was called & instructed.
HIT LIKE A TON OF BRICKS; ACHY FEELING; SCRATCH IN THROAT; COLD CHILLS; TIREDNESS AND FATIGUE; This spontaneous report received from a patient concerned a 42 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B21A, expiry: UNKNOWN) dose was not reported, administered on 10-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-AUG-2021, the patient experienced hit like a ton of bricks. On 11-AUG-2021, the patient experienced achy feeling. On 11-AUG-2021, the patient experienced scratch in throat. On 11-AUG-2021, the patient experienced cold chills. On 11-AUG-2021, the patient experienced tiredness and fatigue. Laboratory data included: SARS-CoV-2 test (NR: not provided) Negative. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hit like a ton of bricks, tiredness and fatigue, achy feeling, cold chills, and scratch in throat. This report was non-serious.
PT COMPLAINED OF ITCHING AND LOSING VOICE.  PT STATED SHE FELT WARM.  PT EVALUATED.  PT DENIED ANY SHORTNESS OF BREATH, CHEST PAIN, NAUSEA OR VOMITING.  PT OBSERVED BY EMS FOR 15 MIN.  PT STATES SHE FEELS BETTER AND SIGNED A REFUSAL OF TRANSPORT.
Patient had an anaphylactic shock after the vaccine, had 2 epi pens  administered by Dr. ,IM of Benadryl and N/S IV. Paramedics were called and took patient to hospital
Shortly after receiving the vaccine the patient reported feeling really dizzy and lightheaded and needed to lay down.
Patient reports joint pain starting day of injection and persisting through this report day 6/30/20
Systemic: Chills-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: AMBULANCE ARRIVED QUICKLY AND TOOK OVER CARE-Mild
Fever; Shaking; Headache; Weakness; Exhaustion; Pain at injection site; Itching at injection site; This is a spontaneous report from a contactable consumer (the patient). A 67-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: E13246), via an unspecified route of administration, administered in right arm on 02Feb2021 08:30 (at the age of 67-years-old) as a single dose for COVID-19 immunization. Medical history included, known allergies to Sulfa, Penicillin, Cephalosporins. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9623), via an unspecified route of administration, administered in right arm on 12Jan2021 09:00 (at the age of 67-years-old) as a single dose for COVID-19 immunization. Concomitant medication included ascorbic acid, copper, tocopheryl acetate, xantofyl, zinc (OCUVIT [ASCORBIC ACID; COPPER; TOCOPHERYL ACETATE; XANTOFYL; ZINC), vitamin d3 (VITAMIN D3), estradiol (ESTRADIOL), magnesium (MAGNESIUM), saccharomyces boulardii (FLORASTOR [SACCHAROMYCES BOULARDII]), all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested COVID-19 post vaccination. On 03Feb2021 01:00, the patient experienced fever, shaking, headache, weakness, exhaustion, pain at injection site, itching at injection site. The patient was not treated for adverse events. The outcome of events was recovered on unspecified date in Feb2021. Follow-up attempts are completed. No further information is expected.
pt devel a nodule on rt underarm 3 days p/vax & the day p/the nodule appeared the pt also c/o nausea;no further info was available @ the date of this report;
After receiving VARIVAX arm turned instantly red around injection site! Ice pack applied. No numbness, tingling or breathing problems. Patient took BENADRYL and ADVIL x 2 days.  Also complained of fatigue and fever on and off.  On 7-31-2008 patients mom states patient is fine and arm looks good.  No redness or selling noted per mom.